• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASMQ Launch

27 April 2008

Rio de Janeiro, Brazil

Farmanguinhos/Fiocruz and DNDi launched ASMQ, the new fixed-dose combination of artesunate (AS) and mefloquine (MQ), now registered in Brazil. Developed and delivered by a worldwide collaboration of public partners, ASMQ will soon be available throughout Latin American and Southeast Asia.

PRESENTATIONS

First Session – Status of Implementation and R&D of Artemisinin-based Combination Therapies (ACTs) (Bernard Pécoul/Drugs for Neglected Diseases initiative – DNDi, Switzerland)

Rationale for ACTs [311KB]

(Piero Olliaro/ Special Programme for Research and Training in Tropical Diseases – TDR, Switzerland) [English]

Status of R&D Portfolio for New Malaria Treatments [477KB]
(J. Carl Craft/Medicines for Malaria Venture – MMV, Switzerland) [English]

Status of ACTs Implementation in Latin America [3.7MB]
(Roberto Montoya/Pan American Health Organization – PAHO, Brazil) [Portuguese/Spanish]

Status of ACTs Implementation in Brazil [414KB]
(José Lázaro de Brito Ladislau/National Program of Malaria Control/ Ministry of Health – PNCM/ MoH, Brazil) [Portuguese]

Second Session – Development of ASMQ combination (Carlos Morel/Fiocruz, Brazil)

FACT: An Innovative Partnership [703KB]
(Jean-René Kiechel/ DNDi, Switzerland) [English]

ASMQ Product Profile: From Blue Print to Blue Pill [2.1MB]
(Jorge Mendonça, Alessandra Viçosa, Luciana Gonçalves and Érico Daemon/ Farmanguinhos – Fiocruz, Brazil) [Portuguese/English]

Pharmacokinetics in Healthy Normal Volunteers and Patients [148KB]
(Michel Vaillant /CRP Santé Luxembourg) [English]

Phase III and Field Studies [1.1MB]
(François Nosten/Shoklo Malaria Research Unit, Thailand) – Presentation prepared by Dr. Elizabeth Ashley [English]

Third Session – Clinical Studies (Piero Olliaro/TDR, Switzerland)

Status of Clinical Studies in Thailand [884KB]
(François Nosten/ Shoklo Malaria Research Unit, Thailand) – Presentation prepared by Dr. Julien Zwang [English]

Status of Clinical Studies in Peru [1.15MB]
(Cristiam Angeles/ Loreto Regional Health Directorate, Peru) [Spanish]

Status of Clinical Studies in Brazil: State of Acre [7.4MB]
(Marize Lucena, Health Surveillance Secretariat – State of Acre; Ana Carolina Santelli/PNCM – MoH, Brazil) [Portuguese]

Status of Clinical Studies in Tanzania: African Perspective [116KB]
(Andrew Kitua/National Institute for Medical Research – NIMR, Tanzania) [English]

Other Planned Clinical Studies, including India and Myanmar
(Isabela Ribeiro/ DNDi, Brazil) [English]

Other events

Loading...
25 June 2025, 12:30 PM Brazil

Online webinar

NTDs around the world – Colombia

18 June 2025

Online

Antiviral Drug Discovery (AViDD) Open Science Forum

16-18 June 2025

São Paulo, Brazil

SciBiz Conference 2025

15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License